Literature DB >> 2296389

Cerebral blood flow variations in CNS lupus.

M J Kushner1, M Tobin, F Fazekas, J Chawluk, D Jamieson, B Freundlich, S Grenell, L Freemen, M Reivich.   

Abstract

We studied the patterns of cerebral blood flow (CBF), over time, in patients with systemic lupus erythematosus and varying neurologic manifestations including headache, stroke, psychosis, and encephalopathy. For 20 paired xenon-133 CBF measurements, CBF was normal during CNS remissions, regardless of the symptoms. CBF was significantly depressed during CNS exacerbations. The magnitude of change in CBF varied with the neurologic syndrome. CBF was least affected in patients with nonspecific symptoms such as headache or malaise, whereas patients with encephalopathy or psychosis exhibited the greatest reductions in CBF. In 1 patient with affective psychosis, without clinical or CT evidence of cerebral ischemia, serial SPECT studies showed resolution of multifocal cerebral perfusion defects which paralleled clinical recovery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296389     DOI: 10.1212/wnl.40.1.99

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01

2.  Central nervous system lupus: concomitant occurrence of myelopathy and cognitive dysfunction.

Authors:  H D Stahl; T H Ettlin; A Plohmann; E W Radü; J Müller-Brand; U Steiger; A Tyndall
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

3.  Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms.

Authors:  K Kodama; S Okada; T Hino; K Takabayashi; Y Nawata; Y Uchida; N Yamanouchi; N Komatsu; T Ikeda; N Shinoda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

4.  Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus.

Authors:  D Ellison; K Gatter; A Heryet; M Esiri
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

5.  18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.

Authors:  F Grünwald; A Schomburg; A Badali; J Ruhlmann; L Pavics; H J Biersack
Journal:  Eur J Nucl Med       Date:  1995-09

Review 6.  Controversies in lupus: nervous system involvement.

Authors:  G A Bruyn
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.